Plasbumin 5 g/20mL (Albumin (Human) SOLUTION) 5 g/20mL

Plasbumin 5 g/20mL is a human albumin solution used for volume expansion and to treat low protein levels. This intravenous solution is manufactured by Grifols USA, LLC.

Strength

5 g/20mL

Pack Size

1 VIAL in 1 CARTON (13533-692-20) / 50 mL in 1 VIAL (13533-692-21)

Manufacturer / TM Owner

GRIFOLS USA, LLC

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

Plasbumin 5 g/20mL is primarily used to increase blood volume in cases of shock, burns, or surgery. It can also be used to treat conditions where protein levels are low, such as in liver disease or severe malnutrition. This solution helps to maintain proper fluid balance and supports overall health.

Side Effects

When administered intravenously, Plasbumin 5 g/20mL works to expand blood volume and improve circulation. It helps to maintain blood pressure and supports the transport of nutrients and hormones throughout the body. The effects are typically seen shortly after administration.

Precautions & Warnings

Plasbumin 5 g/20mL should be used with caution in individuals with heart or kidney disease. It is important to follow the prescribed dosage and administration guidelines provided by a healthcare professional. Always check the solution for any signs of contamination before use.

Avoid Interactions

Plasbumin 5 g/20mL may interact with certain medications, including diuretics and corticosteroids. It is important to inform your healthcare provider about all medications you are taking before starting treatment with this solution. Alcohol consumption should also be discussed with your healthcare provider.

Frequently Asked Questions

Plasbumin 5 g/20mL is used to increase blood volume and treat low protein levels in conditions like shock, burns, or liver disease.

Plasbumin 5 g/20mL is administered intravenously by a healthcare professional.

The common effects include increased blood volume, improved circulation, and support for nutrient and hormone transport.

Yes, it should be used with caution in individuals with heart or kidney disease, and the solution should be checked for contamination before use.

Yes, it may interact with diuretics, corticosteroids, and other medications, so it's important to inform your healthcare provider about all medications you are taking.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated: 29 Jul 2026

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.